Meet Us at SOT 2023 and
See How NeuCyte is Modernizing Neurotoxicity Assessment
Join our scientific presentation
Exhibitor hosted session:
Next Generation Simplified iPSC Neuron-Based Neurotoxicity Assessment Assay with Affordability and Efficiency
March 21, 2023
4:30 PM - 5:30 PM
HiPSC-based systems more closely resemble human biology than animal models and can provide a number of advantages in ethics, efficiency, and predictive power. NeuCyte is dedicated to developing in vitro assays for quantitative assessment of neurological liabilities of compounds using hiPSC-derived neural co-cultures.
Here we present the development of both MEA (microelectrode array)- and Ca imaging-based assays for predicting compounds’ neurotoxicity risks at various doses, from assay design to data processing and interpretation. We will also share how our methodology developed so far demonstrated a better correlation with known clinical data compared to animal-based systems. Such development may expedite the modernization of risk assessment of pharmaceutical and environmental compounds.
Hui Liu, PhD
Head of Drug Discovery, NeuCyte
Martin Nicolson, PhD
Lead Scientist, NeuCyte
Wine, Beer and Nashville-inspired sweets and snacks will be provided!
Visit our booth and see what's new from NeuCyte
Get a copy of our fresh-off-the-press joint application note with Maxwell Biosystems on long-term functional characterization of SynFire® iN/glia co-cultures on the MaxTwo HD MEA platform. The seeding protocol is also available.
Meet us at the Stem Cell Specialty Section Excellence in Research Award Reception
Jointly sponsored by Axion Biosystems and NeuCyte
When: 6:00 PM - 7:30 PM, March 20, 2023
Where: Broadway Ballroom K, Omni Nashville Hotel